<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Jin Y</submitter><funding>the Yan Xiaohua Fujian Provincial Famous Traditional Chinese Medicine Expert Inheritance Studio</funding><funding>the Construction Program for Inheritance Office of National Famous TCM Expert Yan Xiaohua</funding><funding>Science and Technology Innovation Joint Fund Project of the Department of Science and Technology of Fujian Province</funding><funding>the Natural Science Foundation of Fujian Province</funding><funding>the Project for the Construction of Flagship Hospitals for the Collaboration of Traditional Chinese and Western Medicine</funding><pagination>178</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12398093</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>162(1)</volume><pubmed_abstract>Cancer cachexia, a debilitating syndrome characterized by muscle wasting and systemic inflammation, remains a major unmet clinical need. Qingxie Fuzheng Granules (QFG), a traditional Chinese medicine formulation, have shown promise in cancer therapy, but their role in cachexia management is unclear.Here, we investigated the anti-cachectic effects of QFG in a murine model of colon adenocarcinoma-induced cachexia. 16S rRNA sequencing revealed gut dysbiosis in cachectic mice, with increased Enterobacteriaceae and decreased Lactobacillus. QFG treatment restored microbial balance, reduced pro-inflammatory cytokines TNF-α, IL-6, and enhanced intestinal barrier integrity by upregulating tight junction proteins ZO-1, Occludin, Calprotectin.Mechanistically, QFG rebalanced Th17/Treg cell ratios and </pubmed_abstract><journal>Hereditas</journal><pubmed_title>Qingxie Fuzheng granules attenuate cancer cachexia by restoring gut microbiota homeostasis and suppressing IL-6/NF-κB signaling in colorectal adenocarcinoma.</pubmed_title><pmcid>PMC12398093</pmcid><funding_grant_id>Grant No. 2023-697</funding_grant_id><funding_grant_id>Grant No. 2023J01884</funding_grant_id><funding_grant_id>No.2022-75</funding_grant_id><funding_grant_id>2024Y9496</funding_grant_id><pubmed_authors>Lu L</pubmed_authors><pubmed_authors>Hua H</pubmed_authors><pubmed_authors>Fang W</pubmed_authors><pubmed_authors>Ren P</pubmed_authors><pubmed_authors>Chen W</pubmed_authors><pubmed_authors>Geng Z</pubmed_authors><pubmed_authors>Lin J</pubmed_authors><pubmed_authors>Jin Y</pubmed_authors><pubmed_authors>Lin K</pubmed_authors><pubmed_authors>Chen B</pubmed_authors><pubmed_authors>Yan X</pubmed_authors><pubmed_authors>Wang L</pubmed_authors></additional><is_claimable>false</is_claimable><name>Qingxie Fuzheng granules attenuate cancer cachexia by restoring gut microbiota homeostasis and suppressing IL-6/NF-κB signaling in colorectal adenocarcinoma.</name><description>Cancer cachexia, a debilitating syndrome characterized by muscle wasting and systemic inflammation, remains a major unmet clinical need. Qingxie Fuzheng Granules (QFG), a traditional Chinese medicine formulation, have shown promise in cancer therapy, but their role in cachexia management is unclear.Here, we investigated the anti-cachectic effects of QFG in a murine model of colon adenocarcinoma-induced cachexia. 16S rRNA sequencing revealed gut dysbiosis in cachectic mice, with increased Enterobacteriaceae and decreased Lactobacillus. QFG treatment restored microbial balance, reduced pro-inflammatory cytokines TNF-α, IL-6, and enhanced intestinal barrier integrity by upregulating tight junction proteins ZO-1, Occludin, Calprotectin.Mechanistically, QFG rebalanced Th17/Treg cell ratios and </description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Aug</publication><modification>2026-04-08T19:32:43.39Z</modification><creation>2026-04-08T13:45:23.15Z</creation></dates><accession>S-EPMC12398093</accession><cross_references><pubmed>40883855</pubmed><doi>10.1186/s41065-025-00541-1</doi></cross_references></HashMap>